Skip to main content
Figure 1 | Immunity & Ageing

Figure 1

From: Molecular mechanisms associated with the strength of the anti-CMV response in nonagenarians

Figure 1

Pathway categories that were affected by the level of the anti-CMV IgG titre. The numbers of pathways in the indicated pathway categories for nonagenarians are listed. Canonical pathways that were affected by the anti-CMV IgG titre are grouped into pathway categories that are defined in the Ingenuity Knowledge Base®. One canonical pathway can belong to several categories.

Back to article page